The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Gastrointestinal Bleeding Treatment Devices Market Over The Forecast Period?
The gastrointestinal bleeding treatment devices market size has shown strong growth recently. It is anticipated to expand from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This historic expansion can be linked to an increasing occurrence of gastrointestinal disorders, a rise in the prevalence of peptic ulcer disease, the broadening of endoscopic diagnostic procedures, a growth in hospital-based GI interventions, and the wider availability of advanced endoscopy equipment.
The gastrointestinal bleeding treatment devices market size is projected to experience substantial expansion in the coming years, expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by the increasing integration of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a greater focus on early bleeding detection, the expansion of ambulatory surgical centers, and increasing investments in advanced GI care technologies. Prominent trends observed in the forecast period include the growing adoption of advanced endoscopic hemostasis devices, an increase in the use of minimally invasive GI bleeding treatments, escalating demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp
What Primary Factors Are Fueling The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?
The escalating prevalence of gastrointestinal disorders is predicted to significantly enhance market profitability. These conditions are often triggered by factors such as a low fiber diet, chronic stress, insufficient water intake, high consumption of dairy foods, an inactive lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported, based on 2023 data, that 825 per 100,000 Canadians suffer from inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections indicate that this figure could reach 1.1% of the population, or around 470,000 Canadians, by 2035. Therefore, the increasing incidence of GI tract-related disorders is a key market driver.
How Does Segment Analysis Break Down The Gastrointestinal Bleeding Treatment Devices Market Structure?
The gastrointestinal bleeding treatment devices market covered in this report is segmented –
1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices
2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices
3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems
4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents
5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms
What Trends Are Affecting The Gastrointestinal Bleeding Treatment Devices Market Dynamics?
Leading companies within the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to enhance the effectiveness of treating acute bleeding in the GI tract. Hemospray functions as a hemostatic powder engineered to manage and control active GI bleeding. For instance, AIG Hospitals, based in India, launched Hemospray in January 2024, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to address acute gastrointestinal bleeding. Hemospray is particularly recognized for its ease of use, strong safety profile, and capacity to control a wide array of GI bleeds, ranging from peptic ulcers to variceal hemorrhages.
Who Are The Leading Firms Participating In The Gastrointestinal Bleeding Treatment Devices Market?
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC
Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:
Which Regional Market Leads The Gastrointestinal Bleeding Treatment Devices Market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Gastrointestinal Bleeding Treatment Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company
Bleeding Disorders Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Gastrointestinal Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Bleeding Disorder Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model